Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities.
作者信息
Farrugia A
机构信息
Faculty of Health and Medical Sciences, University of Western Australia, Crawley 6009, Australia.
出版信息
Transfus Clin Biol. 2020 Aug;27(3):167-168. doi: 10.1016/j.tracli.2020.05.002. Epub 2020 Jun 12.
Abstract
摘要
相似文献
1
Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities.来自新冠病毒感染康复者的捐赠者血浆——优先事项问题
Transfus Clin Biol. 2020 Aug;27(3):167-168. doi: 10.1016/j.tracli.2020.05.002. Epub 2020 Jun 12.
2
Use of convalescent plasma in COVID-19 patients in China.中国新冠病毒肺炎康复者恢复期血浆在新冠肺炎患者中的应用。
Transfus Clin Biol. 2020 Aug;27(3):168-169. doi: 10.1016/j.tracli.2020.05.001. Epub 2020 May 16.
3
The convalescent sera option for containing COVID-19.使用康复期血清来控制新型冠状病毒肺炎。
J Clin Invest. 2020 Apr 1;130(4):1545-1548. doi: 10.1172/JCI138003.
4
Convalescent plasma, an apheresis research project targeting and motivating the fully recovered COVID 19 patients: A rousing message of clinical benefit to both donors and recipients alike.恢复期血浆，一项针对并激励新冠病毒19康复患者的单采研究项目：对捐赠者和受者都有临床益处的振奋人心的信息。
Transfus Apher Sci. 2020 Jun;59(3):102794. doi: 10.1016/j.transci.2020.102794. Epub 2020 Apr 23.
5
Feasibility of a pilot program for COVID-19 convalescent plasma collection in Wuhan, China.中国武汉 COVID-19 恢复期血浆采集试点项目的可行性。
Transfusion. 2020 Aug;60(8):1773-1777. doi: 10.1111/trf.15921. Epub 2020 Jul 31.
6
Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation.COVID-19 恢复期血浆捐献者的特征和血清学模式：最佳捐献者和捐献时间。
Transfusion. 2020 Aug;60(8):1765-1772. doi: 10.1111/trf.15918. Epub 2020 Jul 6.
7
Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19.6名新冠肺炎康复者恢复期血浆中的抗SARS-CoV-2病毒抗体水平。
Aging (Albany NY). 2020 Apr 22;12(8):6536-6542. doi: 10.18632/aging.103102.
8
Convalescent Plasma and COVID-19.康复期血浆与2019冠状病毒病
JAMA. 2020 Aug 4;324(5):524. doi: 10.1001/jama.2020.10699.
9
Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19.关于制备用于治疗COVID-19患者的免疫血浆的立场文件。
Transfus Apher Sci. 2020 Aug;59(4):102817. doi: 10.1016/j.transci.2020.102817. Epub 2020 May 21.
10
Challenges in the Production of Convalescent Hyperimmune Plasma in the Age of COVID-19.COVID-19时代恢复期超免疫血浆生产面临的挑战
Semin Thromb Hemost. 2020 Oct;46(7):804-806. doi: 10.1055/s-0040-1713433. Epub 2020 Jun 8.
引用本文的文献
1
Convalescent Covid-19 plasma: Back-to-basics and ethics, and next steps.康复期新冠病毒肺炎血浆治疗：回归基础与伦理，以及后续步骤
Transfus Clin Biol. 2021 Aug;28(3):225-227. doi: 10.1016/j.tracli.2021.07.005.
2
What has changed after the COVID-19 pandemic in the publication process? A look-back to "Transfusion clinique et biologique".新冠疫情之后，出版流程发生了哪些变化？回顾《临床与生物学输血》。
Transfus Clin Biol. 2021 May;28(2):129-131. doi: 10.1016/j.tracli.2021.04.001.
3
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.恢复期血浆用于 COVID-19 的预防和治疗：系统评价和定量分析。
JMIR Public Health Surveill. 2021 Apr 7;7(4):e25500. doi: 10.2196/25500.
4
The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19).血红素加氧酶 1（HMOX1）通路作为 2019 年新型冠状病毒（COVID-19，即 SARS-CoV-2）治疗和预防的有前途靶点。
Int J Mol Sci. 2020 Sep 3;21(17):6412. doi: 10.3390/ijms21176412.
5
Passive immunotherapy with convalescent plasma against COVID-19? What about the evidence base and clinical trials?使用康复期血浆对新冠病毒进行被动免疫治疗？证据基础和临床试验情况如何？
Transfus Apher Sci. 2020 Aug;59(4):102858. doi: 10.1016/j.transci.2020.102858. Epub 2020 Jun 27.
本文引用的文献
1
Effectiveness of convalescent plasma therapy in severe COVID-19 patients.恢复期血浆疗法治疗重症 COVID-19 患者的疗效。
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6.
2
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.5 例危重症 COVID-19 患者接受恢复期血浆治疗。
JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.
3
Polyclonal immunoglobulins and hyperimmune globulins in prevention and management of infectious diseases.多克隆免疫球蛋白和高免疫球蛋白在传染病的预防和治疗中的应用。
Infect Dis Clin North Am. 2011 Dec;25(4):773-88. doi: 10.1016/j.idc.2011.07.005.
4
The separation of the antibodies, isoagglutinins, prothrombin, plasminogen and beta1-lipoprotein into subfractions of human plasma.将抗体、同种凝集素、凝血酶原、纤溶酶原和β1-脂蛋白分离成人血浆的亚组分。
J Am Chem Soc. 1949 Feb;71(2):541-50. doi: 10.1021/ja01170a048.
5
Optimised affinity purification of polyclonal antibodies from hyper immunised ovine serum using a synthetic Protein A adsorbent, MAbsorbent A2P.使用合成蛋白A吸附剂MAbsorbent A2P从超免疫羊血清中优化多克隆抗体的亲和纯化。
J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jan 25;814(2):209-15. doi: 10.1016/j.jchromb.2004.10.027.
6
Purification of human immunoglobulin G: a new approach to plasma fractionation.人免疫球蛋白G的纯化：血浆分级分离的新方法。
Vox Sang. 2002 Nov;83(4):332-8. doi: 10.1046/j.1423-0410.2002.00241.x.
Zotero 插件